Herbas VPB

Print
EN | LT
LT - FORMULATION OF (E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4- METHOXYBENZYLSULPHONE WITH ENHANCED STABILITY AND BIOAVAILABILITY
EN - FORMULATION OF (E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4- METHOXYBENZYLSULPHONE WITH ENHANCED STABILITY AND BIOAVAILABILITY

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/00 (2006.01)
A61K 9/0019 (2013.01)
A61K 9/48 (2006.01)
A61K 9/4866 (2013.01)
A61K 47/10 (2017.01)
A61K 31/198 (2013.01)
A61K 31/198 (2006.01)
A61K 47/10 (2013.01)
A61P 35/00 (2006.01)
A61K 31/196 (2013.01)
A61P 35/02 (2006.01)
A61P 35/00 (2018.01)
A61P 35/02 (2018.01)
European patent
(11) Number of the document 3609471
(13) Kind of document T
(96) European patent application number 18718572.3
Date of filing the European patent application 2018-04-13
(97) Date of publication of the European application 2020-02-19
(45) Date of publication and mention of the grant of the patent 2023-01-04
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2018/027514
Date 2018-04-13
PCT application publication
(87) Number WO 2018/191634
Date 2018-10-18
Priority applications
(30) Number Date Country code
201762485355 P 2017-04-13 US
201715688320 2017-08-28 US
PCT/US2017/048890 2017-08-28 WO
Inventors
(72)
MANIAR, Manoj , US
Grantee
(73) Onconova Therapeutics, Inc. , 12 Penns Trail, Newtown, PA 18940, US
Title
(54) FORMULATION OF (E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4- METHOXYBENZYLSULPHONE WITH ENHANCED STABILITY AND BIOAVAILABILITY
  FORMULATION OF (E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4- METHOXYBENZYLSULPHONE WITH ENHANCED STABILITY AND BIOAVAILABILITY